Description

Description

Erli Plus (12.5mg/850mg) is a fixed-dose combination medicine manufactured by PharmaEvo, formulated with Empagliflozin 12.5mg and Metformin 850mg in each tablet. This pack contains 14 tablets and offers an intermediate-strength option within the Erli Plus range, positioned between the lower and higher Metformin doses, for adults with type 2 diabetes mellitus who need a moderately stronger Metformin component alongside the SGLT2-inhibiting action of Empagliflozin. This strength is often selected for patients who are being stepped up from a lower Metformin dose or who need finer dose adjustment based on their glycemic response and tolerability. Metformin works by reducing the liver’s glucose output and improving the body’s sensitivity to insulin, while Empagliflozin lowers blood sugar independently by helping the kidneys remove excess glucose through urine. Combining these two complementary mechanisms into a single tablet is intended to simplify treatment regimens while supporting more thorough blood sugar control. Erli Plus should always be used as part of a broader diabetes management plan that includes appropriate diet, physical activity, and regular blood glucose monitoring, and only under the ongoing supervision of a qualified healthcare provider.

Ingredients

Each tablet of Erli Plus (12.5/850mg) contains two active pharmaceutical ingredients: Empagliflozin 12.5mg, an SGLT2 inhibitor that promotes glucose excretion via the kidneys, and Metformin Hydrochloride 850mg, a biguanide-class antidiabetic agent that decreases hepatic glucose production and enhances insulin sensitivity in body tissues. The formulation also contains standard pharmaceutical excipients, including binding and film-coating agents, which support the tablet’s physical stability and help ensure consistent and reliable release of both active ingredients.

Dosage Form

Erli Plus (12.5/850mg) is available as an oral film-coated tablet, with each tablet delivering a combined strength of 12.5mg Empagliflozin and 850mg Metformin. The pack contains 14 tablets, offering a dosage option suited to patients requiring a mid-range Metformin strength as part of their diabetes treatment plan, as determined by a physician.

Uses

Erli Plus (12.5/850mg) is used to help improve blood sugar control in adults with type 2 diabetes mellitus, particularly for patients who require a moderate increase in Metformin dosage combined with the additional glucose-lowering effect of Empagliflozin. It is often prescribed as a step between lower and higher combination strengths, allowing physicians to fine-tune treatment based on individual response and tolerability. It may also be used alongside other antidiabetic medicines as part of a broader treatment strategy. This medicine is not intended for the treatment of type 1 diabetes or diabetic ketoacidosis.

How to Use

Erli Plus tablets are generally taken with meals, once or twice daily as directed by a doctor, which helps reduce the likelihood of gastrointestinal discomfort associated with the Metformin component. Tablets should be swallowed whole with a glass of water and should not be crushed, split, or chewed unless specifically advised by a healthcare provider. Dosage and treatment duration should strictly follow the physician’s prescription, as these are individualized based on factors such as kidney function, current blood sugar levels, and other medications in use. If a dose is missed, it should be taken as soon as remembered, unless it is close to the time of the next scheduled dose, in which case the missed dose should be skipped rather than doubled.

Side Effects

Erli Plus (12.5/850mg) may cause side effects in some individuals, though not everyone will experience them. Commonly reported effects include gastrointestinal symptoms such as nausea, diarrhea, and stomach discomfort, particularly when treatment is first started, along with urinary tract infections, genital yeast infections, and increased urination associated with the Empagliflozin component. Some patients may also notice dizziness, mild dehydration, or a metallic taste in the mouth. In rare cases, more serious effects such as lactic acidosis (linked to Metformin) or ketoacidosis (linked to Empagliflozin) may occur, requiring immediate medical attention if symptoms such as severe abdominal pain, unusual tiredness, rapid breathing, or persistent vomiting appear.

Pregnancy & Breastfeeding

Erli Plus (12.5/850mg) is generally not recommended for use during pregnancy. While Metformin has been used in specific pregnancy-related circumstances under close medical supervision, the Empagliflozin component is associated with potential risks to fetal development, particularly in later pregnancy stages, and this combination is typically avoided unless directed otherwise by a specialist. Women who are pregnant, planning pregnancy, or suspect they may be pregnant should inform their doctor without delay. The safety of this combination during breastfeeding has not been well established, and alternative diabetes management options are generally considered for nursing mothers. Any decision regarding use during pregnancy or breastfeeding should be made only in consultation with a qualified healthcare provider.

Storage Instructions

Erli Plus tablets should be stored at room temperature in a cool, dry place, protected from direct sunlight, heat, and excess moisture. Tablets should remain in their original packaging until use to guard against environmental exposure. Keep the medicine out of reach of children and pets, and avoid using it beyond the expiry date printed on the pack. Any unused or expired tablets should be disposed of responsibly in line with local pharmaceutical disposal guidelines, rather than being thrown away with regular household waste.

FAQs

Why does Erli Plus come in a 850mg strength specifically?
The 850mg strength offers a mid-range Metformin dose, allowing doctors to adjust treatment gradually between lower and higher combination options based on how a patient responds.

Should this medicine be taken with food?
Yes, taking it with meals is generally recommended to help minimize gastrointestinal discomfort that can occur with the Metformin component.

Can I switch from a different Erli Plus strength to this one?
Any change in strength should only be made under a doctor’s supervision, as it may involve dose adjustment and monitoring of blood sugar and kidney function.

Is regular monitoring required while taking this medicine?
Yes, periodic monitoring of blood sugar levels and kidney function is generally recommended for patients on this combination therapy, as advised by their healthcare provider.

Disclaimer

Always use this medicine strictly according to your doctor’s instructions and prescribed dosage.